ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | -13.3% | 285 | -53.3% | 0.01% | -12.5% |
| Q1 2019 | $15,000 | +15.4% | 610 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $13,000 | +18.2% | 610 | -15.3% | 0.01% | +16.7% |
| Q3 2018 | $11,000 | -8.3% | 720 | 0.0% | 0.01% | -14.3% |
| Q2 2018 | $12,000 | 0.0% | 720 | -2.7% | 0.01% | 0.0% |
| Q1 2018 | $12,000 | +33.3% | 740 | 0.0% | 0.01% | +40.0% |
| Q4 2017 | $9,000 | -99.9% | 740 | +27.6% | 0.01% | -37.5% |
| Q3 2017 | $13,407,000 | +47.0% | 580 | -46.8% | 0.01% | +33.3% |
| Q2 2017 | $9,123,000 | -1.4% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $9,254,000 | +92440.0% | 1,090 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $10,000 | +150.0% | 1,090 | 0.0% | 0.01% | +100.0% |
| Q2 2016 | $4,000 | +100.0% | 1,090 | +113.7% | 0.00% | +200.0% |
| Q1 2016 | $2,000 | – | 510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,850,650 | $75,330,000 | 5.64% |
| BVF INC/IL | 6,682,711 | $28,201,000 | 4.81% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,729,361 | $36,838,000 | 1.49% |
| First Light Asset Management, LLC | 530,391 | $2,238,000 | 0.94% |
| KOPP INVESTMENT ADVISORS LLC | 376,477 | $1,589,000 | 0.78% |
| Sarissa Capital Management LP | 700,000 | $2,954,000 | 0.57% |
| Orbimed Advisors | 10,689,000 | $45,108,000 | 0.41% |
| Bedell Frazier Investment Counselling, LLC | 178,971 | $755,000 | 0.37% |
| PINNACLE ASSOCIATES LTD | 3,453,487 | $14,574,000 | 0.31% |
| Artal Group S.A. | 3,710,000 | $15,656,000 | 0.29% |